Rabbit Recombinant Monoclonal Nrf2 antibody. Carrier free. Suitable for WB, ICC/IF, IHC-P and reacts with Human, Rat, Mouse samples. Immunogen corresponding to Recombinant Fragment Protein within Human NFE2L2.
pH: 7.4
Constituents: 100% PBS
WB | ICC/IF | IHC-P | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Tested | Expected | Tested |
Rat | Tested | Expected | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species Rat | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species Mouse | Dilution info 1/500 - 1/3000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species Mouse | Dilution info 1/100 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
The protein expressed by the NFE2L2 gene functions as a transcription factor that plays a key role in responding to oxidative stress by binding to antioxidant response elements (ARE) in the promoter regions of various cytoprotective genes, such as phase 2 detoxifying enzymes, to promote their expression and neutralize reactive electrophiles. Under normal conditions, it is ubiquitinated and degraded in the cytoplasm by the BCR(KEAP1) complex. However, oxidative stress leads to the inhibition of the BCR(KEAP1) complex, allowing NFE2L2/NRF2 to accumulate in the nucleus, form heterodimers with small Maf proteins, and bind to ARE elements. Additionally, the NFE2L2/NRF2 pathway is activated by selective autophagy, where KEAP1 interacts with SQSTM1/p62, inactivating the BCR(KEAP1) complex and leading to nuclear NFE2L2/NRF2 accumulation and cytoprotective gene expression. It may also be involved in activating genes of the beta-globin cluster by facilitating enhancer activity of hypersensitive site 2 of the beta-globin locus control region. This supplementary information is collated from multiple sources and compiled automatically.
NRF2, NFE2L2, Nuclear factor erythroid 2-related factor 2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2
Rabbit Recombinant Monoclonal Nrf2 antibody. Carrier free. Suitable for WB, ICC/IF, IHC-P and reacts with Human, Rat, Mouse samples. Immunogen corresponding to Recombinant Fragment Protein within Human NFE2L2.
pH: 7.4
Constituents: 100% PBS
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Nrf2 also known as nuclear factor erythroid 2-related factor 2 is a transcription factor with a molecular weight of approximately 66 kDa. It plays a mechanical role in regulating the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. Nrf2 is ubiquitously expressed in various tissues including the liver lungs and skin. Nrf2 activation occurs when it translocates from the cytoplasm to the nucleus to bind the antioxidant response element (ARE) in the DNA starting transcription of target genes.
Nrf2 acts as an important regulator of the cellular antioxidant response. It works in conjunction with its partner protein Keap1 forming a complex that controls its stability and degradation. Under normal conditions Keap1 keeps Nrf2 in the cytoplasm where it is targeted for ubiquitination and degradation. Once activated by oxidative stress or electrophiles Nrf2 dissociates from Keap1 thereby avoiding degradation and relocates to the nucleus to activate the transcription of ARE-dependent genes. This activity boosts the cellular response to oxidative stress by inducing genes involved in detoxification and cellular defense.
Nrf2 plays a significant role in the oxidative stress response and detoxification pathways. Nrf2 activation is linked closely to the PI3K/Akt signaling pathway which influences cell survival growth and metabolism. This pathway also interacts with other important proteins like GSK-3β which can modulate Nrf2 activity and stability. Through these pathways Nrf2 orchestrates a defense mechanism against reactive oxygen species (ROS) by boosting the expression of antioxidant enzymes and detoxifying proteins.
Nrf2 has been associated with conditions like cancer and neurodegenerative diseases. In cancer aberrant Nrf2 activation may lead to enhanced tumor survival by increasing expression of cytoprotective genes which makes cancer cells resistant to chemotherapy. Nrf2 also interacts with proteins such as p53 which play roles in tumor suppression and cellular stress responses. In neurodegenerative disorders reduced Nrf2 activity can contribute to oxidative stress leading to neuron damage and disease progression with proteins like amyloid-beta also being linked with oxidative processes affected by Nrf2 functionality.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Paraffin-embedded mouse salivary gland tissue stained for NRF2 protein at cytoplasm and nucleus with ab313825 at a 1/100 dilution in immunohistochemical analysis.
Antigen Retrieval: Citrate buffer, pH 6.0, 15 min.
Samples were seperated by 5% SDS-PAGE.
All lanes: Western blot - Anti-NRF2 antibody [HL1021] - BSA and Azide free (ab313825) at 1/1000 dilution
Lane 1: Untreated (–) Neuro2A whole cell extracts at 30 µg
Lane 2: Treated (+) Neuro2A whole cell extracts at 30 µg
All lanes: HRP-conjugated anti-rabbit IgG antibody
Predicted band size: 67 kDa
All lanes: Western blot - Anti-NRF2 antibody [HL1021] - BSA and Azide free (ab313825) at 1/1000 dilution
Lane 1: Untreated Rat2 (Rat fibroblast cell line) whole cell extract at 30 µg
Lane 2: Whole cell extract from Rat2 cells treated with 10 uM MG132 for 15 hours at 30 µg
All lanes: HRP-conjugated anti-rabbit IgG antibody
Predicted band size: 68 kDa
All lanes: Western blot - Anti-NRF2 antibody [HL1021] - BSA and Azide free (ab313825) at 1/1000 dilution
Lane 1: Untreated HepG2 (Human liver hepatocellular carcinoma cell line) whole cell extract at 30 µg
Lane 2: Whole cell extract from HepG2 cells treated with 10 uM MG132 for 15 hours at 30 µg
All lanes: HRP-conjugated anti-rabbit IgG antibody
Predicted band size: 68 kDa
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue labeling NRF2 using ab313825 at a 1/100 dilution.
Antigen Retrieval: Citrate buffer, pH 6.0, 15 mins.
Immunofluorescent analysis of mock and 10 µM MG132 for 16 hours treated HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling NRF2 using ab313825 at a 1/500 dilution (green). Blue: Fluoroshield with DAPI.
Cells were 4% paraformaldehyde-fixed.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com